Reuters logo
BRIEF-Amgen receives positive CHMP opinion to expand use of mimpara
2017年6月23日 / 晚上8点26分 / 4 个月前

BRIEF-Amgen receives positive CHMP opinion to expand use of mimpara

June 23 (Reuters) - Amgen Inc:

* Amgen receives positive CHMP opinion to expand use of mimpara (cinacalcet) for the treatment of secondary hyperparathyroidism in certain children with end-stage renal disease on dialysis

* Amgen Inc - CHMP positive opinion will now be reviewed by European Commission Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below